Takeo S, Yasumoto K, Nagashima A, Nakahashi H, Sugimachi K, Nomoto K
Cancer Res. 1986 Jun;46(6):3179-82.
The percentage of tumor-associated macrophages recovered (TAMR) and antitumoral activity of tumor-associated macrophages (TAM) were examined in 77 patients with resectable primary lung cancer. TAM was obtained by plastic adherence following trypsinization. TAMR increased from Stage I to Stage II and decreased in Stage III. It also increased in N1 as compared with N0 and N2 but was unrelated to tumor size. However, the cytostatic activity of TAM declined with advance in stage of the disease and an increase of tumor size, but it was relatively unaffected by the presence of metastasis to regional lymph nodes. There was no correlation between TAMR and the recurrence rate; however, cytostatic activity of TAM was correlated significantly with the prognosis of totally resected cases. TAMR and cytostatic activity of TAM tended to be lower in palliatively resected cases. These results suggest that the assessment of the antitumor activity of TAM, but not merely TAMR, may give prognostic information for lung cancer patients.
对77例可切除的原发性肺癌患者,检测了回收的肿瘤相关巨噬细胞百分比(TAMR)及肿瘤相关巨噬细胞(TAM)的抗肿瘤活性。TAM通过胰蛋白酶消化后贴壁法获得。TAMR从Ⅰ期到Ⅱ期升高,Ⅲ期降低。与N0和N2相比,N1期的TAMR也升高,但与肿瘤大小无关。然而,TAM的细胞抑制活性随疾病分期进展和肿瘤大小增加而下降,但相对不受区域淋巴结转移的影响。TAMR与复发率之间无相关性;然而,TAM的细胞抑制活性与完全切除病例的预后显著相关。姑息性切除病例中,TAMR和TAM的细胞抑制活性往往较低。这些结果表明,评估TAM的抗肿瘤活性,而不仅仅是TAMR,可能为肺癌患者提供预后信息。